Ulrich Knigge

Ulrich Knigge

Guest researcher


  1. Published

    Activity Dose Reduction in 64Cu-DOTATATE PET in Patients with Neuroendocrine Neoplasms: Impact on Image Quality and Lesion Detection Ability.

    Loft, M., Carlsen, Esben Andreas, Johnbeck, C. B., Jensen, C. V., Andersen, Flemming Littrup, Langer, Seppo W., Oturai, P., Knigge, Ulrich & Kjær, Andreas, 2022, In: Molecular Imaging and Biology. 24, p. 600–611

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Published

    A randomised, factorial phase II study to determine the optimal dosing regimen for 68Ga-satoreotide trizoxetan as an imaging agent in patients with gastroenteropancreatic neuroendocrine tumours

    Virgolini, I., Bahri, S., Kjær, Andreas, Gronbaek, H., Iversen, P., Carlsen, E. A., Loft, M., Knigge, Ulrich, Maffey-Steffan, J., Powell, C., Miller, C. G., Rohban, T., McEwan, S. & Czernin, J., 2022, In: Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 63, 3

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Published

    A convolutional neural network for total tumor segmentation in [64Cu]Cu-DOTATATE PET/CT of patients with neuroendocrine neoplasms

    Carlsen, E. A., Lindholm, Kristian, Hindsholm, A., Gæde, M., Ladefoged, C. N., Loft, M., Johnbeck, C. B., Langer, Seppo W., Oturai, P., Knigge, Ulrich, Kjær, Andreas & Andersen, Flemming Littrup, 2022, In: EJNMMI Research. 12, 1, p. 1-10 30.

    Research output: Contribution to journalJournal articleResearchpeer-review

Previous 1 2 Next

ID: 916819